The company develops, manufactures, and distributes fulvic-acid-based nutrient compounds for plant and animal feed in China.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Like it or not, all signals point to China as being one of the great new markets of the 21st century. It's currently the wild west. Many businesses will fold and many others will thrive. Some are shams and many are the real-deal. This one looks genuine to me. Morgan Stanley appears to agree with this assessment, and has invested $50M. Analysts with financially vested interests (shorts) managed to scare the share price down in order to make a profit. Yongye CEO is also putting in $3M and increasing his holdings of common stock. That would indicate he's somewhat confident in the product. Nothing is for sure in China but Yongye seems to offer at least some measure of success.
The markets seem to like it .... Let us hope the climb continues.
Should double in à year! I have followed this stock a year and quadroupled My holdings on the way, and I Will keep on investing more and more as long as they keep on expanding this exciting business in this profitable way!
Does not pay a dividend.
That is the most important safety check for Chinese companies.